REQUEST A DEMO
Total
USD $0.00
Search more companies

Bebetter Med Inc. (广州必贝特医药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bebetter Med Inc. Profile Updated: August 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Chinese Download a sample report

Bebetter Med Inc. (广州必贝特医药股份有限公司) is a company in China, with a head office in Guangzhou. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on January 19, 2012. Its total assets grew by 499.79% over the same period.

Headquarters
The seventh and eighth floors of Building A-3, No. 25, Yaying Stone Road, Science City, Guangzhou High-tech Industrial Development Zone, Guangdong Province
Guangzhou; Guangdong; Postal Code: 510663

Contact Details: Purchase the Bebetter Med Inc. (广州必贝特医药股份有限公司) report to view the information.

Basic Information
Outstanding Shares:
Purchase the Bebetter Med Inc. (广州必贝特医药股份有限公司) report to view the information.
Registered Capital:
Purchase the Bebetter Med Inc. (广州必贝特医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Bebetter Med Inc. (广州必贝特医药股份有限公司) report to view the information.
Incorporation Date:
January 19, 2012
Ownership Details
Purchase this report to view the information.
12.23%
Purchase this report to view the information.
8.91%
Purchase this report to view the information.
7.16%
Purchase this report to view the information.
6.87%
Purchase this report to view the information.
3.72%
Company Performance
Financial values in the chart are available after Bebetter Med Inc. (广州必贝特医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Total Operating Revenue
156.23%
Operating Profit
-32.01%
Net Profit/Loss for the Period
-31.78%
Total Assets
499.79%
Total Equity
569.47%
Return on Equity (ROE)
24.95%
Debt / Equity
-0.42%
Quick Ratio
21.98%
Cash Ratio
17.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?